Education
About Us
Working with TipRanks
Follow Us
Syros Pharmaceuticals (SYRS)
:SYRS
Syros Pharmaceuticals (SYRS) Ownership Overview
10.40% Insiders
1.61% Mutual Funds
18.02% Other Institutional Investors
0.96% ETFs
69.01% Public Companies and
Individual Investors
The ownership structure of Syros Pharmaceuticals (SYRS) stock is a mix of institutional, retail, and individual investors. Approximately 20.59% of the company’s stock is owned by Institutional Investors, 10.40% is owned by Insiders, and 69.01% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 04, 2024 | Nancy Simonian Director | xxxxxxxxxxxxx | $10009 |
| Nov 27, 2024 | Nancy Simonian Director | xxxxxxxxxxxxx | $35025 |
| Nov 20, 2024 | David Roth Cmo | xxxxxxxxxxxxx | $2299 |
| Nov 20, 2024 | xxxxxxxxxxxxx | $7949 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,651,201 | Insider | 9.90% | 335,910 | |
| 1,293,849 | Institution | 4.82% | 119,034 | |
| 257,635 | Institution | 0.96% | 23,702 | |
| 257,635 | Institution | 0.96% | 23,702 | |
| 251,270 | Institution | 0.94% | 23,117 | |
| 170,359 | Institution | 0.63% | 15,673 | |
| 116,754 | Institution | 0.44% | 10,741 | |
| 33,189 | Insider | 0.12% | 3,053 | |
| 16,000 | Insider | 0.06% | 1,472 | |
| 16,000 | Insider | 0.06% | 1,472 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 257,635 | Institution | 0.96% | 23,702 | |
| 170,359 | Institution | 0.63% | 15,673 | |
| 4,191 | Institution | 0.02% | 386 | |
| 312 | Institution | <0.01% | 29 | |
| 68 | Institution | <0.01% | 6 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 257,635 | Institution | 0.96% | 36,893 |
FAQ
Who Owns Syros Pharmaceuticals (SYRS)?
According to the latest TipRanks data, approximately 18.02% of the company's stock is held by institutional investors, 10.40% is held by insiders, and 69.01% is held by retail investors.
What percentage of Syros Pharmaceuticals (SYRS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.02% of Syros Pharmaceuticals (SYRS) stock is held by institutional investors.
What percentage of Syros Pharmaceuticals (SYRS) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.01% of Syros Pharmaceuticals (SYRS) stock is held by retail investors.
Who owns the most shares of Syros Pharmaceuticals (SYRS)?
Raymond Debbane owns the most shares of Syros Pharmaceuticals (SYRS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.